The effect of age on hemopoiesis

Aging Clinical and Experimental Research

Volumn 8, Issue 1, 1996, Pages 1-12

  Quaglino, D ^a,b   Ginaldi, L ^a   Furia, N ^a   De Martinis, M ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Clinica Medica   (Italy)

Author keywords

Aging; Anemias; Hematology; Immunology

Indexed keywords

AGED; AGING; BLOOD CLOTTING; ERYTHROPOIESIS; HEMATOLOGIC DISEASE; HEMATOPOIESIS; HEMOSTASIS; HUMAN; REVIEW; SENESCENCE;

EID: 0029921515     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03340109     Document Type: Review

References (83)

1. Lipschitz D A., Udupa K.B , Milton K.Y., Thompson CO.: Effect of age on hematopoiesis in man Blood 63: 502-509, 1984.
2. Nilsson-Ehle H., Jagenburg R , Landahl S., Svanborg A., Westin J.: Haematological abnormalities and reference intervals in the elderly Acta Med. Scand. 224: 595-604, 1988.
3. Vogel J.M.: Hematologic problems of the aged Mt. Sinai J Med. 47: 150-163, 1980
4. Lipschitz D.A., Mitchell C.O., Thompson C.: The anemia of senescence. Am. J Hematol. 11: 47-54, 1981.
5. Lipschitz D.A., Udupa K.B.: The quantitation of the granulocytic/macrophage committed progenitor cell (CFUc) in man and the mouse. Exp. Hematol. 9: 723-731, 1981.
6. Harman S.M., Tsitouras P.D.; Reproductive hormones in aging men. I Measurement of sex steroids, basal luteinizing hormone, and leydig cell response to human chorionic gonadotropin. J. Clin Endocrinol. Metab. 51: 35-41, 1980.
7. Timiras M.L., Brownstein H.: Prevalence of anemia and correlation of hemoglobin with age in a geriatric screening clinic population. J. Am. Geriatr. Soc. 35. 639-643, 1987.
8. Finch C.A.: Red cell manual. University of Washington, Seattle, 1969, p. 14.
9. Adler S.S : Anaemia in the aged, causes and considerations. Geriatrics 33: 49-59, 1980.
10. Bagicalupo A.: Treatment of severe aplastic anemia. Lectures, XIIIth Meeting of the International Society of Haematology (European & African Division), Istanbul, Turkey, 1995, p.71.
11. Quaglino D., Hayhoe F.G.J.: Haematological Oncology. Churchill Livingstone, London, Edinburgh, 1992.
12. Krantz S.B.: Diagnosis and treatment of pure red cell aplasia. Med. Clin. North Am. 60: 945-952, 1976
13. Linsk J.A., Murray C.K.: Erythrocyte aplasia and hypogammaglobulinemia. Ann. Intern. Med. 55: 831-838, 1969.
14. Mitchell A B.S., Pinn G., Pegrum G.D.: Pure red cell aplasia and carcinoma. Blood 37: 594-597, 1971.
15. Marx J.J.M : Normal iron absorption and decreased red cell iron uptake in the aged Blood 53: 204-211, 1979.
16. Dunlop W.M., James G.W., Hume D.M., Anemia and neutropenia caused by copper deficiency. Ann. Intern. Med. 80: 470, 1974.
17. Badenoch J., Bedford P.D., Evans J.R.: Massive diverticulosis of the small intestine with steatorrhoea and megaloblastic anaemia. Q. J. Med. 24: 321-327, 1955.
18. Carmel R., Kamaze D.S : Physician response to low serum cobalamin levels. Arch. Intern. Med. 146. 1161-1165, 1986.
19. 12 using measurement of serum concentration. J. Lab. Clin. Med. 107: 447-452, 1986.
20. 12 levels. Am J. Med. 82. 291-294, 1987
21. 12 and geriatrics-unanswered questions. Acta Haematol 82: 169-174, 1989.
22. Herbert V.: The megaloblastic anemias. Grune and Stratton, New York, 1959.
23. Herbert V., Megaloblastic anemias. Lab. Invest. 52: 3-19, 1985.
24. Lindenbaum J., Healton E B , Savage D.G., Brust J.G., Garret T.J., Podell E.R., Marcell P.D., Stabler S.P., Allen R.H.: Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med. 318: 1720-1728, 1988.
25. Bergia J.J., Eva anemia. Postgrad. Med. 77: 253-269, 1985
26. Ward H.P., Kumick J.E., Pisarczyk M J.: Serum level of erythropoietin in anemia associated with chronic infection malignancy and primary hematologic disease. J. Clin. Invest. 50: 332-336, 1971.
27. Yawata Y., Howe R., Jacob H.S : Abnormal red cell metabolism causing hemolysis in uremia: defect potentiated by tap water hemodialysis. Ann. Intern. Med. 79: 362-367, 1973.
28. Ward H.P., Gordon B., Pickett J.C.: Serum levels of erythropoietin in rheumatoid arthritis. J. Lab. Clin. Med. 74: 93-98, 1969.
29. Cartwright G.E., Lee G.R.: Annotation: the anemia of chronic disorders. Br. J. Haematol. 21: 147-152, 1971.
30. Francavilla S., Alterazioni ematologiche nelle malattie endocrine. In: Quaglino D. (Ed.), Alterazioni ematologiche in Medicina Interna. Piccin Editore, Padova. 1996.
31. Beregi E., Regius O., Rajczy K.: Comparative study of the morphological changes in lymphocytes of elderly individuals and centenarians. Age Ageing 20: 55-59, 1991.
32. Traill K.M., Jurgens G., Block G., Huber L., Schonitzer D., Widhalm K., Winter U., Wick G.: Analysis of fluorescent low density lipoprotein uptake by lymphocytes. Paradoxical increase in the elderly. Mech. Ageing Dev. 40: 261-288, 1987.
33. Hartsock R J., Smith E.B., Ketter C S., Normal variation with aging of the amount of hematopoietic tissue in bone-marrow from anterior iliac crest. Am. J. Clin. Pathol. 43: 325-333, 1965.
34. Lee M.A., Segal G.M., Bagby G.C.: The hematopoietic microenvironment in the elderly: defects in II1-induced CSF expression in vitro. Exp. Hematol 17: 952-956, 1989.
35. Hellman S , Botnick L.E., Hannon E.C., Vignuelle R.M.: Proliferative capacity of murine hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 75: 490-501, 1978.
36. Mauch P., Botnick L.E., Hannon E.C., Obbagy J., Hellman S.: Decline in bone-marrow proliferative capacity as a function of age. Blood 60: 245-252, 1982.
37. Lansdorp P.M.: Telomere length and proliferation potential of hematopoietic stem cells. J. Cell. Sciences 108: 1-6, 1995.
38. Vaziri H., Schachter F., Uchida I., Wei L., Zhu X., Effros R., Cohen D., Harley C.B., Loss of telomenc DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52: 661-667, 1993
39. Zsebo K.M., Yuschenkoff V.N., Schiffer S., Chang D,. McCall E., Dinarello C.A., Brown M.A., Altrock B., Bagby G.C.: Vascular endothelial cells and granulopoiesis: Interleukin 1 stimulates release of G-CSF and GM-CSF. Blood 71: 99-107, 1988.
40. Herrmann F , Oster W , Meuer S.C., Lindermann A , Mertelsmann R.H.: Interleukin 1 stimulates lymphocytes to produce granulocyte-monocyte colony-stimulating factor. J. Clin Invest. 81: 1415-1418, 1988.
41. Munker R.J., Gasson J., Ogawa M , Koeffler H.P.: Recombinant human TNF induces production of granulocyte-monocyte colony stimulating factor. Nature 323: 79-82, 1986.
42. Murasko D M., Weiner P., Kaye D.: Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin. Exp Immunol. 70: 440-448, 1987
43. Gillis S., Kozak R., Durante M., Weksler M.E.: Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J. Clin. Invest. 67: 937-942, 1981.
44. Staiano-Coico L., Darzynkiewicz Z., Melamed M R., Weksler M.E : Immunological studies of aging. IX. Impaired proliferation of T lymphocytes detected in elderly humans by flow cytometry. J Immunol 132: 1788-1792, 1984.
45. Traill K.N., Ratheiser K , Dietrich M., Sailer S., Zevenbergen J.L., Wicck G., Lack of correlation between serum cholesterol levels, lymphocyte plasma membrane fluidity and mitogen responsiveness in young and aged chickens. Mech. Ageing Dev. 28: 123-138, 1984.
46. Gutowski J K., Innes J., Weksler M.E , Cohen S.: Induction of DNA synthesis in isolated nuclei by cytoplasmic factors. II. Normal generation of cytoplasmic stimulatory factors by lymphocytes from aged humans with depressed proliferative responses. J. Immunol. 132: 559-562, 1984.
47. Gilman S.C., Rosenberg J.S., Feldman J.D.: T lymphocytes from young and aged rats. II Functional defects and the role of interleukin 2 J. Immunol. 128: 644-650, 1982.
48. Cantrell D.A., Smith K.A.: The Interleukin T-cell system: a new cell growth model. Science (Wash. DC) 244: 1312-1316, 1984
49. Nagel J.E., Chopra R.K , Chrest F.J., McCoy M T., Schneider E.L., Holbrook N.J., Adler W.H., Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompained by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J. Clin. Invest. 81: 1096-1102, 1988.
50. Rubin L.A., Jay G., Nelson D.L.: The released interleukin 2 receptor binds interleukin 2 efficiently. J. Immunol. 137: 3841-3844, 1986.
51. Kumar A., Moreau J.L., Baran D., Theze J., Evidence for negative regulation of T cell growth by low affinity interleukin 2 receptors. J. Immunol 138: 1485-1493, 1987.
52. Smith K.A., Cantreil D.A.; Interleukin 2 regulates its own receptors Proc. Natl. Acad Sci. USA 82: 864-868, 1985.
53. Vie H., Miller R.A : Decline with age. in the proportion of mouse T cells that express II2 receptors after mitogen stimulation. Mech. Ageing Dev. 33: 313-322, 1986.
54. Flurkey K., Stadecker M., Miller R.A.: Memory T lymphocyte hyporesponsiveness to non-cognate stimuli: a key factor in age-related immunodeficiency Eur. J. Immunol. 22: 931-935, 1992.
55. Krishnaraj R., Blandford G.: Age-associated alterations in human natural killer cells. I. Increased activity as per conventional and kinetic analysis. Clin. Immunol. Immunopathol. 45: 268-285, 1987.
56. Crawford J., Cohen H.J : Aging and neoplasia. Annu. Rev. Gerontol. Geriatr. 4: 3-32, 1984.
57. Mege J.L., Capo C., Michel B., Gastau J L., Bongrand P.: Phagocytic cell function in aged subjects. Neurobiol. Aging 9: 217-220, 1988.
58. Fulop T., Foris G., Worum I., Paragh G., Leovey A.: Age-related variations of some polymorphonuclear leukocyte functions. Mech. Ageing Dev. 29: 1-8, 1985
59. Babior B.M.: The respiratory burst of phagocytosis J. Clin. invest 73: 599, 1984.
60. Lipschitz D.A., Udupa K.B , Indelicato S R , Das M : Effect of age on second messenger generation in neutrophils. Blood 78: 1347-1354, 1991.
61. Beisel W.R : Single nutrients and immunity. Am. J. Clin. Nuir. 35: 417-468, 1982.
62. Bogden J.D , Oleske J.M , Munves E.M., Lavenhar M.A., Bruening K.S., Kemp F.W., Holding K.S., Denny T.N., Louria T.B.: Zinc and immunocompetence in the elderly baseline data on zinc nutnture and immunity in unsupplemented subjects. Am. J Clin. Nutr. 46: 101-109, 1987.
63. Bick R.L.: Common bleeding and clotting disorders. Med. Clin. North Am. 78: 3, 1994.
64. Meade T.W., Vickers M.V., Thrompson S.G , Stirling Y., Haines A.P., Miller G.J.: Epidemiological characteristics of platelet aggregability. Br. Med J. 290: 428-432, 1985
65. Shreiner D.P., Bell W.R : Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin. Blood 42: 541-547, 1973.
66. Scott B.D.: Heparin-induced thrombocytopenia. Postgrad. Med. 86: 153-155, 1981.
67. 12 deficiency Acta Haematol. 61: 75-79, 1979.
68. Rutherford C.J., Frenkel E P.: Thrombocytopenia: issues in diagnosis and therapy. In. R.L. Bick (Ed.), Common bleeding and clotting disorders. Med. Clin. North Am. 78: 555-575, 1994.
69. Martin J.F., Bath P.M.V., Burr M.L : Influence of platelet size on outcome after myocardial infarction. Lancet 338: 1409-1411, 1991.
70. Martin J.F., Shaw T., Heggie J., Penington D.G.: Measurement of the density of human platelets and its relationship to volume. Br. J. Haematol. 54: 337-352, 1983a.
71. Hendagma P.J., Bainton D.F., Incorporation of a circulating protein into alpha-granules of megakaryocytes. Blood 15: 59-72, 1989.
72. Cramer E.M., Debili N., Martin J.F., Gladwin A M., Breton-Gorius J., Harrison P., Savidge G.F., Vainchenker W.: Uncoordinated expression of fibrinogen compared with thrombospondin and von Willebrand factor in maturing human megakaryocytes. Blood 73:1123-1129, 1989.
73. Trowbridge E.A., Slater D.N., KishK Y.T., Woodcock B.W.: Platelet production in myocardial infarction and sudden cardiac death. Thromb. Haemost. 52: 2701-2705, 1984.
74. Martin J.F.: The relationship between platelet volume and megakaryocytes ploidy Blood Cells 15: 108-117, 1989.
75. Hoffman R.: Regulation of megakaryocytopoiesis Blood 74: 1196-1212, 1989.
76. Arbustini E., Grasso M., Diegli M . Pucci A.: Coronary atherosclerotic plaques with and without thrombus in ischemic heart syndromes: a morphologic, immunohistochemical and biochemical study. Am. J. Cardiol. 68. 36B-49B, 1991.
77. Smith R.E.A , Martin J.F.: Endogenous mediators and thrombophilia In: Meade T.W. (Ed.). Thrombophilia. Bailliere's Clin. Haematol 7: 485-497, 1994.
78. Kannel W.B., Wolf P.A., Castelli W P., D'Agostino R.B.: Fibrinogen and risk of cardiovascular disease. The Framingham study. JAMA 258: 1183-1186, 1987
79. Balleisen L., Bailey J., Epping P.H., Shulte H , Van de Loo J.: Epidemiological study on factor VII. factor VIII and fibrinogen in an industrial population. I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause. Thromb Haemost. 54: 475-479, 1985.
80. Stegnar M., Keber D., Pentek M., Age and sex differences in resting and postocclusion values of tissue plasminogen activator in a healty population. Fibrinolysis 2 (Suppl. 2): 121-122, 1980.
81. Bauer K.A., Weiss L.M , Sparrow D., Vokonas P.S., Rosenberg R.D.: Aging associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study. J. Clin. Invest. 80: 1527-1534, 1987.
82. Bauer K.A., Kass B.L., Cate H C., Hawinger J J. Rosenberg R.D.: Factor IX is activated in vivo by the tissue factor mechanism. Blood 76. 731-736, 1990.
83. Cadroy Y , Pierrejean D., Fontan B., Sie P., Boneu B.: Influence of aging on the activity of the haemostatic system: prothrombin fragment 1+2 thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years. Now. Rev Fr. Hematol. 34: 43-46, 1992.